Pennant Investors as of March 31, 2024
Portfolio Holdings for Pennant Investors
Pennant Investors holds 44 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amazon (AMZN) | 13.2 | $53M | 296k | 180.38 | |
| TransDigm Group Incorporated (TDG) | 12.8 | $52M | 42k | 1231.60 | |
| Antero Res Call Option (AR) | 11.7 | $47M | 1.6M | 29.00 | |
| Microsoft Corporation (MSFT) | 11.7 | $47M | 112k | 420.72 | |
| Micron Technology (MU) | 8.9 | $36M | 306k | 117.89 | |
| Echostar Corp Cl A (SATS) | 7.6 | $31M | 2.2M | 14.25 | |
| Alphabet Cap Stk Cl A (GOOGL) | 7.4 | $30M | 199k | 150.93 | |
| Apple Put Option (AAPL) | 6.8 | $27M | 160k | 171.48 | |
| Colfax Corp (ENOV) | 6.2 | $25M | 400k | 62.45 | |
| ODP Corp. (ODP) | 5.3 | $21M | 400k | 53.05 | |
| Perimeter Solutions Sa Common Stock | 4.2 | $17M | 2.3M | 7.42 | |
| Fibrogen | 0.4 | $1.8M | 768k | 2.35 | |
| Arcutis Biotherapeutics (ARQT) | 0.4 | $1.7M | 171k | 9.91 | |
| Altimmune Com New (ALT) | 0.3 | $1.1M | 110k | 10.18 | |
| Fate Therapeutics (FATE) | 0.3 | $1.1M | 146k | 7.34 | |
| Nurix Therapeutics (NRIX) | 0.2 | $835k | 57k | 14.70 | |
| Macrogenics (MGNX) | 0.2 | $645k | 44k | 14.72 | |
| Igm Biosciences (IGMS) | 0.2 | $626k | 65k | 9.65 | |
| Enanta Pharmaceuticals (ENTA) | 0.2 | $613k | 35k | 17.46 | |
| Allogene Therapeutics (ALLO) | 0.1 | $574k | 128k | 4.47 | |
| 89bio (ETNB) | 0.1 | $518k | 45k | 11.64 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $511k | 32k | 15.76 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $448k | 24k | 18.88 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.1 | $442k | 13k | 33.77 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $442k | 15k | 29.24 | |
| Travere Therapeutics Note 2.500% 9/1 | 0.1 | $430k | 56k | 7.71 | |
| Getaround (GETR) | 0.1 | $414k | 1.3M | 0.31 | |
| Zymeworks Del (ZYME) | 0.1 | $407k | 39k | 10.52 | |
| Coherus Biosciences (CHRS) | 0.1 | $402k | 168k | 2.39 | |
| Compass Therapeutics (CMPX) | 0.1 | $394k | 199k | 1.98 | |
| Relay Therapeutics (RLAY) | 0.1 | $352k | 42k | 8.30 | |
| Erasca (ERAS) | 0.1 | $342k | 166k | 2.06 | |
| Sage Therapeutics (SAGE) | 0.1 | $328k | 18k | 18.74 | |
| Novavax Com New (NVAX) | 0.1 | $288k | 60k | 4.78 | |
| Agenus Com New | 0.1 | $272k | 470k | 0.58 | |
| Uniqure Nv SHS (QURE) | 0.1 | $252k | 49k | 5.20 | |
| Replimune Group (REPL) | 0.1 | $249k | 31k | 8.17 | |
| Bioxcel Therapeutics | 0.1 | $237k | 84k | 2.82 | |
| Allakos | 0.1 | $235k | 186k | 1.26 | |
| Seres Therapeutics | 0.1 | $226k | 292k | 0.77 | |
| Allovir (ALVR) | 0.0 | $163k | 216k | 0.75 | |
| Airspan Networks Holdings (MIMOQ) | 0.0 | $118k | 1.0M | 0.11 | |
| Bluebird Bio | 0.0 | $112k | 87k | 1.28 | |
| Grab Holdings *w Exp 99/99/999 (GRABW) | 0.0 | $16k | 80k | 0.20 |
